$STE (Steris Plc)

$STE {{ '2016-08-09T11:05:40+0000' | timeago}} • Announcement

$STE said that its BoD has authorized a $0.03 increase in its quarterly interim dividend to $0.28 per share. The dividend is payable Sept. 27, 2016 to shareholders of record at the close of business on Aug. 30, 2016. The company's BoD has also authorized the purchase of up to $300MM of ordinary shares.

$PG {{ '2017-07-28T16:27:39+0000' | timeago}} • Webcast

$PG expects net impact of interest expense, interest income, and other non-operating income to be 1-2 point headwind on FY18 core EPS growth. $PG sees core effective tax rate to be around 24%, roughly in line with the FY17 rate. $PG plans to deliver another year of 90% or better free cash flow productivity. This includes CapEx of 5-5.5% of sales.

$PG {{ '2017-07-28T16:12:44+0000' | timeago}} • Webcast

In April, $PG took price reductions in the U.S. on male blades and razors to restore a more evenly spaced pricing ladder. In May, $PG repositioned and relaunched Gillette Shave Care, the shave club with Gillette on-demand. North America shave care grew volume in 4Q17 for the first time after eight consecutive quarters of volume declines.

$PG {{ '2017-07-28T16:01:25+0000' | timeago}} • Webcast

$PG's Tide PODS and Gain Flings! have driven 90% of U.S. laundry detergent category growth since they were introduced. Today, those products generate 15% of category sales with P&G holding nearly 80% share of form. $PG expects this form to continue leading category growth. In 2017, 23% of households had tried unit dose detergents, up 40% from 2016.

$ABBV {{ '2017-07-28T15:50:59+0000' | timeago}} • Infographic

$ABBV AbbVie, Inc. Earnings AlphaGraphics: Q2 2017 highlights

$ABBV {{ '2017-07-28T12:13:15+0000' | timeago}} • Announcement

Global HUMIRA sales for $ABBV rose 13.7% in 2Q17, while Global IMBRUVICA net revenues jumped 42.6%. The gross margin ratio in the second quarter was 78.0%, with adjusted gross margin ratio at 82.3%.

$ABBV {{ '2017-07-28T12:04:31+0000' | timeago}} • Announcement

While posting 2Q17 results, $ABBV confirmed its GAAP diluted EPS guidance for FY17 of $4.55-4.65. AbbVie expects to deliver adjusted diluted EPS of $5.44 to $5.54, representing growth of 13.% at the mid-point.

$ABBV {{ '2017-07-28T12:02:43+0000' | timeago}} • Announcement

With the biopharma giant's net revenues up 7.6% to $6.9Bil in 2Q17, $ABBV's net earnings soared 19% to $1.9Bil or $1.19 per share.  Adjusted diluted EPS was $1.42, up 12.7% in the quarter.

$PG {{ '2017-07-27T12:19:14+0000' | timeago}} • Announcement

$PG expects 1Q18 results to be the lowest organic sales and core EPS growth period of the year, as the period compares against the highest organic growth base period. Top-line headwinds from portfolio choices and the recent Gillette price reduction in the US will primarily impact 1H18 and will annualize as the year progresses.

$PG {{ '2017-07-27T12:18:04+0000' | timeago}} • Announcement

$PG expects FY18 core EPS of 5-7% versus core EPS of $3.92 in FY17. $PG said it expects core EPS growth in FY18 to be driven primarily by core operating profit growth. All-in GAAP earnings per share are expected to decrease 26-28% versus FY17 GAAP EPS of $5.59.

$PG {{ '2017-07-27T12:16:41+0000' | timeago}} • Announcement

$PG expects FY18 organic sales growth in the range of 2-3%. $PG estimates all-in sales growth of about 3% for FY18, which includes a neutral to half-a-percentage point benefit to sales growth from the combined impacts of foreign exchange and acquisitions & divestitures.

$PG {{ '2017-07-27T12:13:23+0000' | timeago}} • Announcement

$PG's Fabric & Home Care segment organic sales rose 5% versus year ago. Fabric Care and Home Care organic sales both increased mid-single digits due to increased volume from product innovation. Baby, Feminine & Family Care segment organic sales were unchanged versus prior year.

$PG {{ '2017-07-27T12:11:45+0000' | timeago}} • Announcement

$PG's Health Care segment organic sales declined 1% for 4Q17. Oral Care organic sales decreased low single digits due to competitive activity and reduced pricing on paste. Personal Health Care organic sales decreased low single digits due to an earlier cough and cold season versus prior year along with reductions in trade inventories.

$PG {{ '2017-07-27T12:10:19+0000' | timeago}} • Announcement

$PG's Beauty segment organic sales for 4Q17 increased 5%. Organic sales were up high single digits in Skin & Personal Care on continued growth of super-premium SK-II skin care brand and higher pricing behind product innovation. Organic sales rose low single digits in Hair Care, on higher pricing across multiple regions and brands.

$PG {{ '2017-07-27T12:08:05+0000' | timeago}} • Infographic

$PG, which had a disappointing sales growth run lately, said Grooming segment organic sales for 4Q17 slid 1%, on lower pricing in Shave Care. Organic sales fell low single digits in Shave Care due to lower pricing in US. Gillette franchise is taking hit from value-based store brands and disruptive online offerings such as $UL's Dollar Shave Club.

$PII {{ '2017-07-27T12:05:16+0000' | timeago}} • Announcement

$PII has declared a regular quarterly cash dividend of $0.58 per share on its common stock. The dividend is payable on September 15, 2017, to shareholders of record as on September 1, 2017.

$PG {{ '2017-07-27T11:44:05+0000' | timeago}} • Infographic

$PG Procter & Gamble Earnings AlphaGraphic: Q4 2017 Highlights

$PG {{ '2017-07-27T11:37:53+0000' | timeago}} • Announcement

Consumer products giant $PG reported a 14% growth in earnings driven by lower costs and expenses. Net income grew 14% to $2.2Bil from last year and EPS increased 19% to $0.82. Core EPS rose 8% to $0.85. Sales remained unchanged at $16.1Bil. Organic sales rose 2% driven by a 2% increase in organic shipment volume.

$EW {{ '2017-07-26T20:43:20+0000' | timeago}} • Announcement

For 3Q17, $EW projects underlying sales, adjusting for the impact of Germany stocking sales consumption, to be between $810-850MM, and adjusted earnings per share of $0.80 to $0.90.

$EW {{ '2017-07-26T20:42:56+0000' | timeago}} • Announcement

For FY17, $EW's full year sales estimate is now at the high end of its previous $3.2-3.4Bil guidance. Edwards Lifesciences Corp is also raising its estimate for FY17 adjusted earnings per share to $3.65-3.85, from $3.43-3.55.

$EW {{ '2017-07-26T20:40:21+0000' | timeago}} • Announcement

With strong demand for TAVR therapy resulted in total sales growth of 15% on an underlying basis, $EW's 2Q17 sales soared 11% to $841.8MM. Net income for the quarter jumped 47% to $186.1MM or $0.86 per diluted share. Adjusted earnings per share grew 42.1% to $1.08 while underlying sales rose 15% to about $864MM.

Recent Transcripts

ALGN (Align Technology Inc.)
Thursday, July 27 2017 - 8:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, July 27 2017 - 8:30pm
JCI (Johnson Controls Inc.)
Thursday, July 27 2017 - 3:00pm
MTRN (Materion Corporation)
Thursday, July 27 2017 - 1:00pm
PG (The Procter & Gamble Company)
Thursday, July 27 2017 - 12:30pm
SNN (Smith & Nephew plc)
Thursday, July 27 2017 - 8:00am
EW (Edwards Lifesciences Corp.)
Wednesday, July 26 2017 - 9:00pm
IART (Integra LifeSciences Holdings Corporation)
Wednesday, July 26 2017 - 12:30pm
ISRG (Intuitive Surgical, Inc.)
Thursday, July 20 2017 - 8:30pm
PII (Polaris Industries Inc.)
Thursday, July 20 2017 - 2:00pm
VRML (Vermillion, Inc.)
Thursday, May 11 2017 - 12:30pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
STE (Steris Plc)
Tuesday, May 9 2017 - 2:00pm
XRAY (DENTSPLY International Inc.)
Tuesday, May 9 2017 - 12:30pm
ATRS (Antares Pharma Inc.)
Tuesday, May 9 2017 - 12:30pm
ENDP (Endo International plc)
Tuesday, May 9 2017 - 12:30pm
IVC (Invacare Corporation)
Tuesday, May 9 2017 - 12:30pm
SNN (Smith & Nephew plc)
Friday, May 5 2017 - 7:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 9:00pm
SRCL (Stericycle, Inc.)
Thursday, May 4 2017 - 9:00pm

AlphaGraphics you may like